IRTC Depositi SEC - iRhythm Technologies, Inc.- Relazione annuale, dichiarazione di delega, prospetto informativo

Statistiche di base

LEI	549300FJI72RJGDQS384
CIK	1388658

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to iRhythm Technologies, Inc.

SEC Filings (Chronological Order)

Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.

July 31, 2025	EX-99.1	iRhythm Technologies Announces Second Quarter 2025 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2025 Financial Results SAN FRANCISCO, July 31, 2025 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2025. Second Quarter 2025 Financial Highlights •Revenue
July 31, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
July 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2025 iRhythm Technologie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
July 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2025 iRhythm Technologies UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
July 7, 2025	EX-99.1	iRhythm Technologies Announces Board Member Retirements and New Director Appointments SAN FRANCISCO, JULY 7, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutio iRhythm Technologies Announces Board Member Retirements and New Director Appointments SAN FRANCISCO, JULY 7, 2025 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc.
May 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 28, 2025 iRhythm Technologies UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 28, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 21, 2025	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, California 94103 (Address of
May 21, 2025	EX-1.01	iRhythm Technologies, Inc. Conflict Minerals Report for the reporting period January 1, 2024 to December 31, 2024 Exhibit 1.01 iRhythm Technologies Inc. Conflict Minerals Report For the Reporting Period from January 1, 2024 to December 31, 2024 This Conflict Minerals Report, ("Report"), of iRhythm Technologies Inc., ("the Company", “we” or “our”), for the period January 1, 2024 to December 31, 2024, ("the Reporting Period"), has been prepared pursuant to Rule 13p-1, ("Rule 13p-1" or "the Rule"), under the Sec
May 1, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 1, 2025	EX-99.1	iRhythm Technologies Announces First Quarter 2025 Financial Results Exhibit 99.1 iRhythm Technologies Announces First Quarter 2025 Financial Results SAN FRANCISCO, May 1, 2025 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights •Revenue of
May 1, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 1, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
April 16, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 16, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
February 20, 2025	EX-19.1	Insider Trading Policy 1 INSIDER TRADING POLICY THIS POLICY WAS APPROVED BY THE BOARD ON FEBRUARY 5, 2025 PURPOSE iRhythm Technologies, Inc.
February 20, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 20, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
February 20, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
February 20, 2025	EX-99.1	iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results Exhibit 99.1 iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results SAN FRANCISCO, February 20, 2025 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 202
February 20, 2025	EX-10.20+	ulting Agreement dated August 28, 2024 Page 1 of 7 IRHYTHM TECHNOLOGIES, INC. SEPARATION AGREEMENT AND CONSULTING AGREEMENT This Separation Agreement and General Release of Claims (this “Agreement”) confirms the agreement between iRhythm Technologies, Inc. (the “Company”) and Brice Bobzien (“Executive”) concerning the terms of Executive’s separation, and offers certain payments and benefits in exchange for Executive’s agreement to a ge
February 20, 2025	EX-10.21+	, by and between the Registra iRhythm Technologies, Inc. • 650 Townsend Street, Suite 500 • San Francisco, CA 94103 phone: 415.632.5700 • fax: 415.632.5701 • irhythmtech.com June 28, 2019 Daniel Wilson [email protected] Dear Dan: We are pleased to offer you the position of Executive Vice President, Strategy & Corporate Development with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will recei
February 20, 2025	EX-21.1	List of Subsidiaries of Registrant. Exhibit 21.1 List of Subsidiaries iRhythm Technologies Limited Company Name Place of Incorporation iRhythm Technologies Limited United Kingdom iRhythm Singapore PTE. Ltd. Singapore iRhythm Japan GK (1) Japan iRhythm Philippines, Inc. (1) Philippines iRhythm Technologies Netherlands B.V. Netherlands (1) This an indirect subsidiary through iRhythm Singapore PTE. Ltd.
January 27, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2025 iRhythm Technolo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
January 13, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 13, 2025 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
January 13, 2025	EX-99.1	iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, January 13, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading dig iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.
November 14, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
November 14, 2024	EX-10.1	016 Equity Incentive Plan and related form agreements IRHYTHM TECHNOLOGIES, INC. 2016 EQUITY INCENTIVE PLAN As amended November 7, 2024. 1.Purposes of the Plan. The purposes of this Plan are: •to attract and retain the best available personnel for positions of substantial responsibility, •to provide additional incentive to Employees, Directors and Consultants, and •to promote the success of the Company’s business. The Plan permits the grant of Incent
November 12, 2024	SC 13G/A	IRTC / iRhythm Technologies, Inc. / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* iRhythm Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 450056106 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriat
November 12, 2024	SC 13G/A	IRTC / iRhythm Technologies, Inc. / Artisan Partners Limited Partnership - SC 13G/A Passive Investment SC 13G/A 1 d886768dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. Under the Securities Exchange Act of 1934 (Amendment No. 1 )* iRhythm Technologies Inc. (Name of Issuer) Common Stock (Tit
November 12, 2024	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 d886768dex991.htm EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 11/12/2024 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTI
November 7, 2024	SC 13G/A	IRTC / iRhythm Technologies, Inc. / SANDS CAPITAL MANAGEMENT, LLC - SC 13G/A Passive Investment SC 13G/A 1 d871375dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO Section 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO Section 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 4) * iRhythm Technologies, Inc. (Name of Issuer) Comm
October 30, 2024	EX-10.1	echnology License Agreement dated August 30, 2024 between Registrant and BioIntelliSense, Inc. *CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL* TECHNOLOGY LICENSE AGREEMENT This Technology License Agreement (this “Agreement”) is entered into as of August 30, 2024 (the “Effective Date”) by and between iRhythm Technologies, Inc.
October 30, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 30, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
October 30, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name
October 30, 2024	EX-99.1	iRhythm Technologies Announces Third Quarter 2024 Financial Results Exhibit 99.1 iRhythm Technologies Announces Third Quarter 2024 Financial Results SAN FRANCISCO, October 30, 2024 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2024. Third Quarter 2024 Financial Highlights •Re
October 10, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 10, 2024 iRhythm Technolo UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 10, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
October 10, 2024	EX-99.1	iRhythm Technologies Shareholder Engagement Fall 2024 2© 2024 iRhythm Technologies, Inc. BUSINESS OVERVIEW & YTD 2024 ACCOMPLISHMENTS CORPORATE GOVERNANCE & BOARD COMPOSITION Agenda for upcoming dialogue EXECUTIVE COMPENSATION SUSTAINABILITY & CORPOR iRhythm Technologies Shareholder Engagement Fall 2024 2© 2024 iRhythm Technologies, Inc.
September 4, 2024	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
September 4, 2024	EX-99.1	Exhibit 99.1 iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerom Exhibit 99.1 iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring iRhythm granted exclusive license to BioIntelliSense’s patented pulse oximetry, accelerometry and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring (ACM) market SAN FRANCISCO, SEPTEMBER 4, 2024
August 1, 2024	EX-99.2	iRhythm Technologies Announces Chief Financial Officer Transition Exhibit 99.2 iRhythm Technologies Announces Chief Financial Officer Transition SAN FRANCISCO, August 1, 2024 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that Brice Bobzien, Chief Financial Officer, will step down for personal reasons effective August 31, 2024. He
August 1, 2024	EX-3.1	Amended and Restated Certificate of Incorporation, as amended, of the Registrant. IRHYTHM TECHNOLOGIES, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION iRhythm Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: A. The name of the Corporation is iRhythm Technologies, Inc., and the original Certificate of Incorporation of this Corporation was filed with the Secretary of State of
August 1, 2024	EX-99.1	iRhythm Technologies Announces Second Quarter 2024 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2024 Financial Results SAN FRANCISCO, August 1, 2024 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2024. Second Quarter 2024 Financial Highlights •Revenue
August 1, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
August 1, 2024	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 31, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
May 31, 2024	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 31, 2024	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. exhibit31-chartercertifi CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IRHYTHM TECHNOLOGIES, INC.
May 30, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, California 94103 (Address of
May 30, 2024	EX-1.01	iRhythm Technologies, Inc. Conflict Minerals Report for the reporting period January 1, 2023 to December 31, 2023. Exhibit 1.01 iRhythm Technologies Inc. Conflict Minerals Report For the Reporting Period from January 1, 2023 to December 31, 2023 This Conflict Minerals Report, ("Report"), of iRhythm Technologies Inc., ("the Company", “we” or “our”), for the period January 1, 2023 to December 31, 2023, ("the Reporting Period"), has been prepared pursuant to Rule 13p-1, ("Rule 13p-1" or "the Rule"), under the Sec
May 2, 2024	EX-99.1	iRhythm Technologies Announces First Quarter 2024 Financial Results Exhibit 99.1 iRhythm Technologies Announces First Quarter 2024 Financial Results SAN FRANCISCO, May 2, 2024 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Financial Highlights •Revenue of
May 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 2, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 2, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
April 11, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
April 11, 2024	ARS	2023 Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ FORM 10-K ____________________________________________ p04413irtcx10kwrapx2024 2023 Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
April 11, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
March 28, 2024	PRE 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
March 8, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
March 8, 2024	EX-99.1	[Signature Page to [Base][Additional] Capped Call Confirmation] Exhibit 99.1 [Dealer name and address] [March ], 2024 To: iRhythm Technologies, Inc. 699 8th Street, Suite 600 San Francisco, CA 94103 Attention: Legal Department Re: [Base][Additional] Call Option Transaction The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option transaction entered into between [] (“Dealer”) and iRhythm Technologies,
March 8, 2024	EX-4.1	Indenture dated March 7, 2024 between iRhythm Technologies, Inc. and U.S. Bank Trust Company, National Association, as trustee (including the form of 1.50% Convertible Senior Notes due 2029). Exhibit 4.1 IRHYTHM TECHNOLOGIES, INC. 1.50% CONVERTIBLE SENIOR NOTES DUE 2029 INDENTURE DATED AS OF MARCH 7, 2024 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS TRUSTEE TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 10 Section 1.03. Rules of Construction 11 Section 1.04. References to Additional Interest 1
March 8, 2024	EX-99.2	IRHYTHM ANNOUNCES CLOSING OF $661.25 MILLION OF 1.50% CONVERTIBLE SENIOR NOTES DUE 2029, INCLUDING FULL EXERCISE OF INITIAL PURCHASERS’ $86.25 MILLION OPTION TO PURCHASE ADDITIONAL NOTES Exhibit 99.2 IRHYTHM ANNOUNCES CLOSING OF $661.25 MILLION OF 1.50% CONVERTIBLE SENIOR NOTES DUE 2029, INCLUDING FULL EXERCISE OF INITIAL PURCHASERS’ $86.25 MILLION OPTION TO PURCHASE ADDITIONAL NOTES SAN FRANCISCO, MARCH 8, 2024 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict
March 5, 2024	EX-99.1	IRHYTHM PRICES UPSIZED OFFERING OF $575.0 MILLION OF 1.50% CONVERTIBLE SENIOR NOTES DUE 2029 Exhibit 99.1 IRHYTHM PRICES UPSIZED OFFERING OF $575.0 MILLION OF 1.50% CONVERTIBLE SENIOR NOTES DUE 2029 SAN FRANCISCO, MARCH 4, 2024 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 million aggreg
March 5, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
March 4, 2024	EX-99.1	IRHYTHM ANNOUNCES PROPOSED OFFERING OF $450.0 MILLION OF CONVERTIBLE SENIOR NOTES Exhibit 99.1 IRHYTHM ANNOUNCES PROPOSED OFFERING OF $450.0 MILLION OF CONVERTIBLE SENIOR NOTES SAN FRANCISCO, MARCH 4, 2024 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to market conditions and othe
March 4, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2024 iRhythm Technologie UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
February 22, 2024	EX-21.1	List of Subsidiaries of Registrant. Exhibit 21.1 List of Subsidiaries iRhythm Technologies Limited Company Name Place of Incorporation iRhythm Technologies Limited United Kingdom iRhythm Singapore PTE. Ltd. Singapore iRhythm Japan GK (1) Japan iRhythm Philippines, Inc. (1) Philippines (1) This an indirect subsidiary through iRhythm Singapore PTE. Ltd.
February 22, 2024	EX-10.17	Executive Change in Control and Severance Policy as Amended. Exhibit 10.17 IRHYTHM TECHNOLOGIES, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE POLICY (Adopted on August 1, 2019; Effective as of September 1, 2019; Amended May 23, 2023) This Executive Change in Control and Severance Policy, as amended (the “Policy”) is designed to provide certain protections to a select group of key employees of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) or any
February 22, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 22, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
February 22, 2024	EX-10.10	dated May 31, 2019 between the Registrant and Big Dog Holdings LLC. Exhibit 10.10 First Amendment to Office Lease This First Amendment to Office Lease (this “Amendment”) is being signed on May 31, 2019 (the “Effective Date”), by Big Dog Holdings LLC, a Delaware limited liability company (“Landlord”), and iRhythm Technologies, Inc., a Delaware corporation (“Tenant”). Recitals A.Pursuant to that certain Office Lease dated as of October 4, 2018 (the “Existing Lease”;
February 22, 2024	EX-97.1	Compensation Recovery Policy Exhibit 97.1 iRhythm Technologies, Inc. Compensation Recovery Policy (Adopted August 10, 2023) The Board has determined that it is in the best interests of the Company and its stockholders to adopt this Policy enabling the Company to recover from specified current and former Company executives certain incentive-based compensation in the event of an accounting restatement resulting from material no
February 22, 2024	EX-3.1	Amended and Restated Certificate of Incorporation of the Registrant, as amended. Exhibit 3.1 IRHYTHM TECHNOLOGIES, INC. AMENDED AND RESTATED CERTIFICATE OF INCORPORATION iRhythm Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: A. The name of the Corporation is iRhythm Technologies, Inc., and the original Certificate of Incorporation of this Corporation was filed with the Secretary
February 22, 2024	EX-10.8	Amendment to the Third Amended and Restated Loan and Security Agreement dated Exhibit 10.8 THIRD AMENDMENT TO THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT This Third Amendment to Third Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into this 17th day of November, 2023, by and between SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (“Bank”) and IRHYTHM TECHNOLOGIES, INC., a Delaware corporation (“Borrower”), wh
February 22, 2024	EX-99.1	iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results Exhibit 99.1 iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results SAN FRANCISCO, February 22, 2024 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 202
February 22, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
February 13, 2024	SC 13G/A	IRTC / iRhythm Technologies, Inc. / SANDS CAPITAL MANAGEMENT, LLC Passive Investment SC 13G/A 1 irtc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO Section 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO Section 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 3) * iRhythm Technologies, Inc. (Name of Issuer) Common Stock, par v
February 13, 2024	SC 13G/A	IRTC / iRhythm Technologies, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01228-irhythmtechnologiesi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: iRhythm Technologies Inc Title of Class of Securities: Common Stock CUSIP Number: 450056106 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box t
February 12, 2024	EX-99.1	JOINT FILING AGREEMENT EX-99.1 2 d758132dex991.htm EX-99.1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree to the joint filing of the Schedule 13G to which this Agreement is attached. Dated: 2/12/2024 ARTISAN PARTNERS ASSET MANAGEMENT INC, for itself and as the general partner of ARTISAN PARTNERS HOLDINGS LP By: Gregory K. Ramirez * ARTISAN INVESTMENTS GP LLC, for itself and as the general partner of ARTIS
February 12, 2024	SC 13G	IRTC / iRhythm Technologies, Inc. / Artisan Partners Limited Partnership - SC 13G Passive Investment SC 13G 1 d758132dsc13g.htm SC 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2. Under the Securities Exchange Act of 1934 (Amendment No. )* iRhythm Technologies Inc (Name of Issuer) Common Stock (Title of Class of Secur
February 9, 2024	SC 13G	IRTC / iRhythm Technologies, Inc. / Capital Research Global Investors - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* iRhythm Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 450056106 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box
January 8, 2024	EX-99.1	Exhibit 99.1 iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, JANUARY 8, 2024 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (NASDAQ:IRTC), a Exhibit 99.1 iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference SAN FRANCISCO, JANUARY 8, 2024 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary four
January 8, 2024	EX-10.1	Credit, Security and Guaranty Agreement, dated January 3, 2024, by and among the Company, Braidwell Transaction Holdings LLC – Series 5 and Wilmington Trust, National Association. Exhibit 10.1 Execution Version CREDIT, SECURITY AND GUARANTY AGREEMENT dated as of January 3, 2024 among IRHYTHM TECHNOLOGIES, INC., as the Borrower, any guarantor that hereafter becomes party hereto, each as Guarantor, and collectively as Guarantors, THE LENDERS FROM TIME TO TIME PARTY HERETO and WILMINGTON TRUST, NATIONAL ASSOCIATION, as the Agent TABLE OF CONTENTS ARTICLE I DEFINITIONS AND ACCO
January 8, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2024 iRhythm Technolog UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 3, 2024 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
November 16, 2023	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 10, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
November 16, 2023	EX-3.1	Amended and Restated Bylaws of the Registrant (as amended and restated on November 10, 2023). AMENDED AND RESTATED BYLAWS OF IRHYTHM TECHNOLOGIES, INC. (As Amended and Restated on November 10, 2023) i TABLE OF CONTENTS Page ARTICLE I — CORPORATE OFFICES........................................................................................1 1.1 REGISTERED OFFICE...........................................................................................1 1.2 OTHER OFFICES ...................
November 2, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 2, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
November 2, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name
November 2, 2023	EX-99.1	iRhythm Technologies Announces Third Quarter 2023 Financial Results Exhibit 99.1 iRhythm Technologies Announces Third Quarter 2023 Financial Results SAN FRANCISCO, November 2, 2023 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and nine months ended September 30, 2023. Third Quarter 2023 Financial Highl
August 15, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 11, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
August 10, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
August 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
August 3, 2023	EX-99.1	iRhythm Technologies Announces Second Quarter 2023 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2023 Financial Results SAN FRANCISCO, August 3, 2023 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and six months ended June 30, 2023. Second Quarter 2023 Financial Results •Re
August 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2023 iRhythm Technologi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
June 6, 2023	EX-99.1	iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments Exhibit 99.1 iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments SAN FRANCISCO, JUNE 6, 2023 (GLOBE NEWSWIRE) – iRhythm Technologies, Inc.(NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the appointment of Mojdeh Poul and Brian Yoor as dire
June 6, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 6, 2023 iRhythm Technologies UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 6, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
June 6, 2023	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 1, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 31, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, California 94103 (Address of
May 31, 2023	EX-1.01	iRhythm Technologies, Inc. Conflict Minerals Report for the reporting Exhibit 1.01 iRhythm Technologies Inc. Conflict Minerals Report For the Reporting Period from January 1, 2022 to December 31, 2022 This Conflict Minerals Report, ("Report"), of iRhythm Technologies Inc., (" the Company", “we” or “our”), for the period January 1, 2022 to December 31, 2022, ("the Reporting Period"), has been prepared pursuant to Rule 13p-1, ("Rule 13p-1" or "the Rule"), under the Se
May 30, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 25, 2023 iRhythm Technologies UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 25, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 25, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 24, 2023 iRhythm Technologies UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 24, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 4, 2023	EX-99.1	iRhythm Technologies Announces First Quarter 2023 Financial Results Exhibit 99.1 iRhythm Technologies Announces First Quarter 2023 Financial Results SAN FRANCISCO, May 4, 2023 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three months ended March 31, 2023. First Quarter 2023 Financial Results •Revenue of $11
May 4, 2023	EX-10.1	Resignation, Release and Consulting Agreement, dated March 10, 2023, by and between the Registrant and Douglas Devin Exhibit 10.1 March 10, 2023 Re: Resignation and Release Agreement Dear Douglas: This letter confirms the agreement (“Agreement”) between you and iRhythm Technologies, Inc., a Delaware corporation (the “Company”) concerning the terms of your resignation and offers you the separation compensation, benefits, and consulting agreement we discussed in exchange for a general release of claims and covenan
May 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2023 iRhythm Technologies, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 4, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
May 1, 2023	DEFR14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi
April 12, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
March 15, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2023 iRhythm Technologi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
March 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2023 iRhythm Technologi UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 10, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
February 23, 2023	EX-10.22	Offer Letter, dated July 22, 2022, by and between the Registrant and Brice Bobzien. Exhibit 10.22 Dear Brice Bobzien, We are pleased to offer you the position of Chief Financial Officer with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefits from time to time as it deems necessary. If you decide to joi
February 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 23, 2023 iRhythm Technol UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 23, 2023 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
February 23, 2023	EX-10.19	Offer Letter, dated November 15, 2021, by and between the Registrant and Patrick Murphy. Exhibit 10.19 November 15, 2021 Patrick Michael Murphy via email: [email protected] Dear Patrick: We are pleased to offer you the position of General Counsel of iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefit
February 23, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
February 23, 2023	EX-21.1	List of Subsidiaries of Registrant. Exhibit 21.1 List of Subsidiaries Company Name Country Date of Incorporation Registration No. iRhythm Technologies Inc. US (Delaware) September 14, 2006 4211384 iRhythm Technologies Limited UK March 10, 2016 10055682 iRhythm Singapore Pte. Ltd. Singapore June 24, 2021 202120787H iRhythm Japan GK (1) Japan June 7, 202 #0110-03-014840 (1) Japan is a subsidiary of Singapore
February 23, 2023	EX-10.20	Offer Letter, dated April 24, 2022, by and between the Registrant and Minang Pravin Turakhia, MD. Exhibit 10.20 April 24, 2022 Minang Pravin Turakhia, MD 1490 Southdown Road Hillsborough, CA 94010 Dear Dr. Turakhia: We are pleased to offer you the position of Chief Scientific Officer and Chief Medical Officer with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Comp
February 23, 2023	EX-10.21	Offer Letter, dated July 18,2022, by and between the Registrant and Chad Patterson. Exhibit 10.21 Dear Chad Patterson, We are pleased to offer you the position of Chief Commercial Officer with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefits from time to time as it deems necessary. If you decide to j
February 23, 2023	EX-99.1	iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results Exhibit 99.1 iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results SAN FRANCISCO, February 23, 2023 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months and full year ended December 31, 202
February 14, 2023	SC 13G/A	IRTC / Irhythm Technologies Inc / SANDS CAPITAL MANAGEMENT, LLC Passive Investment SC 13G/A 1 13ga2irhythm.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO Section 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO Section 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2) iRhythm Technologies, Inc. (Name of Issuer) Common Stock, par
February 9, 2023	SC 13G/A	IRTC / Irhythm Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01187-irhythmtechnologiesi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: iRhythm Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 450056106 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box
November 7, 2022	SC 13G/A	IRTC / Irhythm Technologies Inc / JPMORGAN CHASE & CO - FILING IRHYTHM TECHNOLOGIES, INC. Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* iRhythm Technologies, Inc. (Name of Issuer) Common Stock, Par Value $.001 Per Share (Title of Class of Securities) 450056106 (CUSIP Number) October 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box t
November 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name
November 1, 2022	EX-99.1	iRhythm Technologies Announces Third Quarter 2022 Financial Results Exhibit 99.1 iRhythm Technologies Announces Third Quarter 2022 Financial Results SAN FRANCISCO, November 1, 2022 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today reported financial results for the three months ended September 30, 2022. Third Quarter 2022 Financial Results ?Reven
November 1, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 1, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
September 21, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 21, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or org
September 21, 2022	EX-99.1	iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day Exhibit 99.1 iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day SAN FRANCISCO, September 21, 2022 ? iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predict disease, will discuss the Company?s strategies for long-term growth, provide an update on its innovation pipeline and sha
September 21, 2022	EX-99.2	2022 Analyst & Investor Day September 21, 2022 2© 2022 iRhythm Technologies, Inc. Welcome DAN WILSON Executive Vice President, Corporate Strategy 3© 2022 iRhythm Technologies, Inc. Safe Harbor Certain data in this presentation was obtained from vario 2022 Analyst & Investor Day September 21, 2022 2? 2022 iRhythm Technologies, Inc. Welcome DAN WILSON Executive Vice President, Corporate Strategy 3? 2022 iRhythm Technologies, Inc. Safe Harbor Certain data in this presentation was obtained from various external sources, and neither iRhythm Technologies, Inc. (?iRhythm? or the ?Company?) nor its affiliates or representatives has verified such data
August 5, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
August 5, 2022	EX-99.1	iRhythm Technologies Announces Second Quarter 2022 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2022 Financial Results SAN FRANCISCO, August 4, 2022 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022. Second Quarter 2022 Financial Highlights ?Revenue of $102.1 million, a 25.6%
August 5, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
July 25, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 25, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
July 25, 2022	EX-10.1	Offer Letter between the Company and Brice Bobzien dated July 25, 2022 Exhibit 10.1 Dear Brice Bobzien, We are pleased to offer you the position of Chief Financial Officer with iRhythm Technologies, Inc. (the ?Company?). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefits from time to time as it deems necessary. If you decide to join
July 25, 2022	EX-99.1	iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) ? iRhythm Technologies, Inc.
July 19, 2022	EX-10.1	Resignation and Release of Claims by and between iRhythm Technologies, Inc. and David A. Vort, dated July 18, 2022 Exhibit 10.1 RESIGNATION AND RELEASE OF CLAIMS This Resignation and Release of Claims (?Agreement?) is made by and between David Vort (?Employee?) and iRhythm Technologies, Inc. (the ?Company?) (collectively referred to as the ?Parties? or individually referred to as a ?Party?). RECITALS WHEREAS, Employee was employed by the Company; WHEREAS, Employee signed an invention assignment and confidentia
July 19, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
July 19, 2022	EX-99.1	iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022 iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022 SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) ? iRhythm Technologies, Inc.
June 2, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 26, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
June 1, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction SD 1 d330080dsd.htm SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, Calif
May 6, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 5, 2022	EX-99.1	iRhythm Technologies Announces First Quarter 2022 Financial Results Exhibit 99.1 iRhythm Technologies Announces First Quarter 2022 Financial Results SAN FRANCISCO, May 5, 2022 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2022. First Quarter 2022 Financial Highlights ?Revenue of $92.4 million, a 24.3% incre
May 5, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
April 14, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 IRHYTHM TECHNOLOGIES, INC. 699 8th Street, Suite 600 San Francisco, California 94103 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Stateme
March 29, 2022	EX-10.1	Second Amendment to the Third Amended and Restated Loan and Security Agreement dated March 28, 2022, by and between the Company and Silicon Valley Bank. SECOND AMENDMENT TO THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT This Second Amendment to Third Amended and Restated Loan and Security Agreement (this ?Amendment?) is entered into this 28th day of March, 2022, by and between SILICON VALLEY BANK (?Bank?) and IRHYTHM TECHNOLOGIES, INC.
March 29, 2022	EX-99.1	iRhythm Technologies Announces Amendment to Term Loan Agreement Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 Exhibit 99.1 iRhythm Technologies Announces Amendment to Term Loan Agreement Provides enhanced credit facility up to $100 million with favorable terms and facility maturity extended to March 2027 SAN FRANCISCO, March 29, 2022 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing
March 29, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 28, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
March 14, 2022	EX-99.1	iRhythm® Technologies Announces Kevin King to Retire from Board of Directors iRhythm? Technologies Announces Kevin King to Retire from Board of Directors SAN FRANCISCO, March 14, 2022 - iRhythm Technologies, Inc.
March 14, 2022	EX-10.1	Resignation and Release Agreement, dated March 13, 2022, between iRhythm Technologies, Inc. and Kevin M. King. Exhibit 10.1 RESIGNATION AND RELEASE AGREEMENT This Resignation and Release Agreement (?Agreement?) is made by and between Kevin King (?Mr. King?) and iRhythm Technologies, Inc. (the ?Company?) (collectively referred to as the ?Parties? or individually referred to as a ?Party?). 1.Resignation. Effective as of April 1, 2022 (the ?Effective Date?), Mr. King will resign from the Company?s Board of Di
March 14, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 14, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
March 2, 2022	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Techn
February 28, 2022	EX-10.43	First Amendment to Development Collaboration Agreement by and among the Registrant, Verily Life Sciences LLC and Verily Ireland Limited. *Certain identified information has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed* AMENDMENT NO.
February 28, 2022	EX-FILING FEES	Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) iRhythm Technologies, Inc (Exact name of registrant as specified in its charter) Table 1 ? Newly Registered Securities Security Type Securities Class Type Fee Calculation Rule Amount to be Registered(1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Co
February 28, 2022	EX-10.44	Second Amendment to Development Collaboration Agreement by and among the Registrant, Verily Life Sciences LLC and Verily Ireland Limited. *Certain identified information has been excluded from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed* AMENDMENT NO.
February 28, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
February 28, 2022	S-8	As filed with the Securities and Exchange Commission on February 28, 2022 As filed with the Securities and Exchange Commission on February 28, 2022 Registration No.
February 23, 2022	EX-99.1	iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results Exhibit 99.1 iRhythm Technologies Announces Fourth Quarter and Full Year 2021 Financial Results SAN FRANCISCO, February 23, 2022 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2021. Fourth Quarter 2021 Financial Highlights ?
February 23, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 23, 2022 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
February 10, 2022	SC 13G/A	IRTC / Irhythm Technologies Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: iRhythm Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 450056106 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is fi
January 24, 2022	SC 13G	IRTC / Irhythm Technologies Inc / JPMORGAN CHASE & CO - FILING IRHYTHM TECHNOLOGIES, INC. Passive Investment SC 13G 1 iRhythmTechnologiesInc.h.htm FILING IRHYTHM TECHNOLOGIES, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* iRhythm Technologies, Inc. (Name of Issuer) Common Stock, Par Value $.001 Per Share (Title of Class of Securities) 450056106 (CUSIP Number) December 31, 2021 (Date of Event Which Requ
December 14, 2021	EX-10.2	Promotion Letter, executed December 10, 2021, between iRhythm Technologies, Inc. and David A. Vort. December 8, 2021 VIA EMAIL Dear Dave: You are being offered the position of Chief Commercial Officer (?CCO?) of iRhythm Technologies, Inc.
December 14, 2021	EX-10.1	Promotion Letter, executed December 9, 2021, between iRhythm Technologies, Inc. and Douglas J. Devine. December 8, 2021 VIA EMAIL Dear Doug: You are being offered the position of Chief Operating Officer (?COO?) of iRhythm Technologies, Inc.
December 14, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 9, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
December 1, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 1, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
November 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name
November 4, 2021	EX-99.1	iRhythm Technologies Announces Third Quarter 2021 Financial Results Exhibit 99.1 iRhythm Technologies Announces Third Quarter 2021 Financial Results SAN FRANCISCO, November 4, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended September 30, 2021. Third Quarter 2021 Financial Highlights ?Revenue was $85.4 million, a
November 4, 2021	8-K	Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 3, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
October 12, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 6, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
October 12, 2021	EX-99.1	iRhythm® Technologies Announces Changes to Its Board of Directors Karen Ling Appointed to the Board; Raymond Scott to Retire iRhythm? Technologies Announces Changes to Its Board of Directors Karen Ling Appointed to the Board; Raymond Scott to Retire SAN FRANCISCO, October 12, 2021 - iRhythm Technologies, Inc.
September 13, 2021	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2021 iRhythm Techno UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or org
September 13, 2021	EX-99.1	iRhythm® Technologies Names Quentin Blackford President and Chief Executive Officer Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies iRhythm? Technologies Names Quentin Blackford President and Chief Executive Officer Accomplished MedTech Leader with Proven Track Record of Strategic, Operational and Financial Execution with High Growth Companies SAN FRANCISCO, September 13, 2021 - iRhythm Technologies, Inc.
September 13, 2021	EX-10.1	Offer Letter, dated September 8, 2021, by and between the Registrant and Quentin S. Blackford. September 8, 2021 Dear Quentin: We are pleased to offer you the position of President and Chief Executive Officer of iRhythm Technologies, Inc.
September 13, 2021	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 13, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or o
September 3, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, California 94103 (Address of
August 9, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
August 5, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 5, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
August 5, 2021	EX-99.1	iRhythm Technologies Announces Second Quarter 2021 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2021 Financial Results SAN FRANCISCO, August 5, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2021. Second Quarter 2021 Financial Highlights ?Revenue was $81.3 million, a 59.8%
July 9, 2021	SC 13G/A	IRTC / Irhythm Technologies Inc / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 4)* iRhythm Technologies, Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 450056106 (CUSIP Number) Eddie C. Brow
July 6, 2021	EX-10.2	Consulting Agreement by and between the Company and Michael Coyle dated June 29, 2021 IRHYTHM TECHNOLOGIES, INC. CONSULTING AGREEMENT This Consulting Agreement (this ?Agreement?) is made and entered into as of June 7, 2021 (the ?Effective Date?) by and between iRhythm Technologies, Inc., a Delaware corporation with its principal place of business at 699 8th Street, Suite 600, San Francisco California (the ?Company?), and Michael Coyle, an individual (?Consultant?) (each herein refe
July 6, 2021	EX-10.1	Separation Agreement and Release by and between the Company and Michael Coyle dated June 29, 2021 SEPARATION AGREEMENT AND RELEASE This Separation Agreement and Release (?Agreement?) is made by and between Michael J.
July 6, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 29, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
July 6, 2021	EX-10.3	Offer Letter dated July 2, 2021 by and between the Company and Douglas Devine July 2, 2021 VIA EMAIL Douglas J. Devine, CPA 12 Keefer Court Piedmont, CA 94610 Dear Doug: You have agreed to serve as Interim Chief Executive Officer (?Interim CEO?) of iRhythm Technologies, Inc. (the ?Company?) during the Company?s search for a Chief Executive Officer. This letter sets forth the terms and conditions of the Interim CEO role, which is in addition to your role as Chief Financial O
June 21, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 18, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
June 4, 2021	S-8	As filed with the Securities and Exchange Commission on June 3, 2021 As filed with the Securities and Exchange Commission on June 3, 2021 Registration No.
June 1, 2021	EX-99.1	iRhythm® Technologies Announces Leadership Transition President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted Exhibit 99.1 iRhythm? Technologies Announces Leadership Transition President and CEO Michael Coyle Steps Down Due to Personal Matters Douglas Devine to Serve as Interim CEO While Search for Permanent CEO is Conducted SAN FRANCISCO, June 1, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced tha
June 1, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 1, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
May 10, 2021	EX-10.42	Multi-Tenant Office/Industrial Lease by and between iRhythm Technologies, Inc. and Katella/Holder Street LLC dated March 18, 2021. MULTI-TENANT OFFICE/INDUSTRIAL LEASE (NNN) CYPRESS DISTRIBUTION CENTER Cypress, California LANDLORD: KATELLA/HOLDER STREET, LLC, a Delaware limited liability company TENANT: IRHYTHM TECHNOLOGIES, INC.
May 10, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 6, 2021	EX-99.1	IRHYTHM TECHNOLOGIES, INC. Condensed Consolidated Balance Sheets (In thousands, except share and per share data) March 31, 2021 December 31, 2020 Assets Current assets: Cash and cash equivalents $ 137,375 $ 88,628 Short-term investments 124,911 246,5 Exhibit 99.1 iRhythm Technologies Announces First Quarter 2021 Financial Results SAN FRANCISCO, May 6, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2021. First Quarter 2021 Financial Highlights ?Revenue was $74.3 million, a 17% incre
May 6, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
April 30, 2021	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
April 12, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 12, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
April 12, 2021	EX-99.1	iRhythm® Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas’s Updated Rate Publication and Provides Commentary on Results for the First Quarter 2021 Exhibit 99.1 iRhythm? Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas?s Updated Rate Publication and Provides Commentary on Results for the First Quarter 2021 SAN FRANCISCO, April 12, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recent publication by
February 26, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
February 25, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 25, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
February 25, 2021	EX-99.1	iRhythm Technologies Announces Fourth Quarter and Full Year 2020 Financial Results Exhibit 99.1 iRhythm Technologies Announces Fourth Quarter and Full Year 2020 Financial Results SAN FRANCISCO, February 25, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months and full year ended December 31, 2020. Fourth Quarter 2020 Financial Highlights ?
February 16, 2021	SC 13G/A	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* iRhythm Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 450056106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
February 12, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* iRhy UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 3)* iRhythm Technologies, Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 450056106 (CUSIP Number) Eddie C. Brow
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2)* Name of issuer: iRhythm Technologies Inc. Title of Class of Securities: Common Stock CUSIP Number: 450056106 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is fi
February 4, 2021	SC 13G/A	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* iRhythm Technologies, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 450056106 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which
February 1, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 29, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
February 1, 2021	EX-99.1	iRhythm Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas Recent Rate Publication Exhibit 99.1 iRhythm Technologies Provides Statement on Medicare Administrative Contractor (MAC) Novitas Recent Rate Publication SAN FRANCISCO, January 29, 2021 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recent publication by Novitas Solutions (“Novitas”) of rates applicable to the Curren
January 28, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 25, 2021 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
January 28, 2021	EX-10.1	Transition Agreement by and between iRhythm Technologies, Inc. and Kevin M. King dated January 25, 2021 Exhibit 10.1 TRANSITION AGREEMENT This Transition Agreement (“Agreement”) is made by and between Kevin King (“Executive”) and iRhythm Technologies, Inc. (the “Company”) (collectively, Executive and the Company referred to as the “Parties” or individually referred to as a “Party”). RECITALS WHEREAS, Executive was employed by the Company; WHEREAS, Executive signed an Offer Letter with the Company on
December 14, 2020	EX-10.1	Offer Letter, dated December 10, 2020, by and between iRhythm Technologies, Inc. and Michael J. Coyle. Exhibit 99.1 December 10, 2020 Michael J. Coyle Dear Mike: We are pleased to offer you the position of President and Chief Executive Officer of iRhythm Technologies, Inc. (the “Company”) and it will be expected that you join the Company’s Board of Directors (the “Board”). In this capacity, you will be responsible for the overall management of the Company, reporting to the Board. You shall devote y
December 14, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 14, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
December 14, 2020	EX-99.1	iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021 Exhibit 99.1 iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021 SAN FRANCISCO, December 14, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective Janua
December 2, 2020	8-K	Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 2, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
December 2, 2020	EX-99.1	iRhythm Technologies Comments on Centers for Medicare and Medicaid Services 2021 Medicare Physician Fee Schedule Final Rule Webcast Scheduled for December 2, 2020 at 5:30 am PT/8:30 am ET Exhibit 99.1 iRhythm Technologies Comments on Centers for Medicare and Medicaid Services 2021 Medicare Physician Fee Schedule Final Rule Webcast Scheduled for December 2, 2020 at 5:30 am PT/8:30 am ET SAN FRANCISCO, December 2, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the Centers for M
November 16, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 16, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or orga
November 16, 2020	EX-99.1	ZIO BY IRHYTHM DETECTS PREVIOUSLY UNDIAGNOSED ATRIAL FIBRILLATION AND HELPS TO PREVENT HOSPITALIZATIONS, STROKE, AND DEATH AS A RESULT Exhibit 99.1 ZIO BY IRHYTHM DETECTS PREVIOUSLY UNDIAGNOSED ATRIAL FIBRILLATION AND HELPS TO PREVENT HOSPITALIZATIONS, STROKE, AND DEATH AS A RESULT a.Three-Year Study Results Presented at 2020 American Heart Association Scientific Sessions b.Zio Supports Better Healthcare Utilization Rates and Patient Outcomes With Ambulatory Cardiac Monitoring SAN FRANCISCO, November 16, 2020 (GLOBE NEWSWIRE) - i
November 6, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name
November 5, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 5, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
November 5, 2020	EX-99.1	iRhythm Technologies Announces Third Quarter 2020 Financial Results Exhibit 99.1 iRhythm Technologies Announces Third Quarter 2020 Financial Results SAN FRANCISCO, November 5, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended September 30, 2020. Third Quarter 2020 Summary •Revenue of $71.9 million ◦31.6% increase c
October 6, 2020	10-Q/A	Quarterly Report - 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission file number: 001-37918 iRhythm Technologies, Inc
October 6, 2020	CORRESP	* * * October 6, 2020 VIA EDGAR AND COURIER United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Mail Stop 3030 Washington, D.
October 6, 2020	10-Q/A	Quarterly Report - 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A (Amendment No. 1) (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934Commission file number: 001-37918 iRhythm Technologies, Inc
August 21, 2020	EX-1.1	Underwriting Agreement by and among iRhythm Technologies, Inc. and J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the several underwriters named therein, dated August 18, 2020. Exhibit 1.1 EXECUTION VERSION iRhythm Technologies, Inc. 1,093,167 Shares of Common Stock Underwriting Agreement August 18, 2020 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 L
August 21, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 18, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
August 19, 2020	424B4	1,093,167 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Nos. 333-244399 and 333-248118 1,093,167 Shares Common Stock We are offering 1,093,167 shares of our common stock. Our common stock is listed on The Nasdaq Global Select Market under the symbol “IRTC.” Per Share Total Public offering price $ 175.00 $ 191,304,225.00 Underwriting discounts and commissions (1) $ 10.50 $ 11,478,253.50 Proceeds to iRhythm T
August 19, 2020	S-1MEF	- S-1MEF As filed with the Securities and Exchange Commission on August 19, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 IRHYTHM TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) Delaware 3841 20-8149544 (State or other jurisdiction of incorporation or organization
August 18, 2020	S-1/A	- S-1/A Registration No. 333-244399 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 IRHYTHM TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) Delaware 3841 20-8149544 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Co
August 17, 2020	CORRESP	- J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10017 Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 August 17, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: iRhythm Technologies, Inc. Registration Statement on Form S-1 (File No. 333-244399) Request for Acceleration of Effective
August 17, 2020	CORRESP	- August 17, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason L. Drory and Celeste Murphy Re: iRhythm Technologies, Inc. Registration Statement on Form S-1 File No. 333-244399 Acceleration Request Requested Date: August 18, 2020 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rul
August 14, 2020	CORRESP	- iRhythm Technologies, Inc. August 14, 2020 Page 1 Via EDGAR and Overnight Delivery U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason L. Drory Celeste Murphy Re: iRhythm Technologies, Inc. Registration Statement on Form S-1 Filed August 11, 2020 File No. 333-244399 CIK No. 0001388658 S-1/A filed
August 14, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 14, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
August 14, 2020	S-1/A	- S-1/A Registration No. 333-244399 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 IRHYTHM TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) Delaware 3841 20-8149544 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Co
August 14, 2020	EX-1.1	Form of Underwriting Agreement Exhibit 1.1 iRhythm Technologies, Inc. [•] Shares of Common Stock Underwriting Agreement [•], 2020 J.P. Morgan Securities LLC Morgan Stanley & Co. LLC As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Morgan Stanley & Co. LLC 1585 Broadway New York, New York 10036 Ladies and Gentlemen: iRhythm T
August 14, 2020	EX-3.1	Certificate of Amendment to the Amended and Restated Bylaws. Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE BYLAWS OF IRHYTHM TECHNOLOGIES, INC. (Adopted on August 14, 2020) The undersigned, being the duly acting and appointed Secretary of iRhythm Technologies, Inc., a Delaware corporation (the “Company”), hereby certifies that, by action of the board of directors of the Company on August 14, 2020, the Bylaws (the “Bylaws”) of the Company have been amended as
August 11, 2020	S-1	Registration Statement - S-1 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 IRHYTHM TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) Delaware 3841 20-8149544 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employ
August 11, 2020	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 11, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organi
August 7, 2020	EX-10.1	Executive Change in Control and Severance Policy IRHYTHM TECHNOLOGIES, INC. EXECUTIVE CHANGE IN CONTROL AND SEVERANCE POLICY (Adopted on August 1, 2019; Effective as of September 1, 2019) This Executive Change in Control and Severance Policy (the “Policy”) is designed to provide certain protections to a select group of key employees of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) or any of its subsidiaries if their employment is invol
August 7, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of Re
August 7, 2020	8-K/A	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organ
August 7, 2020	EX-99.1	iRhythm Technologies Announces Second Quarter 2020 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2020 Financial Results SAN FRANCISCO, August 6, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2020. Second Quarter 2020 Summary •Revenue of $50.9 million ◦3% decrease compared
August 6, 2020	EX-99.1	iRhythm Technologies Announces Second Quarter 2020 Financial Results Exhibit 99.1 iRhythm Technologies Announces Second Quarter 2020 Financial Results SAN FRANCISCO, August 6, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2020. Second Quarter 2020 Summary •Revenue of $50.9 million ◦3% decrease compared
August 6, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
August 4, 2020	EX-99.2	iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Medicare Physician Fee Schedule Exhibit 99.2 iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Medicare Physician Fee Schedule SAN FRANCISCO, August 4, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recently released Centers for Medicare and Medicaid Services (“CMS”) Calendar
August 4, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 4, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
August 4, 2020	EX-99.1	iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule Exhibit 99.1 iRhythm Technologies Comments on the Centers for Medicare and Medicaid Services 2021 Proposed Physician Fee Schedule SAN FRANCISCO, August 4, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the recently released Centers for Medicare and Medicaid Services (“CMS”) Calendar Year 202
June 23, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 19, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
June 23, 2020	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF IRHYTHM TECHNOLOGIES, INC. Kevin King certifies that: 1.He is the Chief Executive Officer of iRhythm Technologies, Inc., a Delaware corporation (the “Corporation”). 2.The name of the Corporation is iRhythm Technologies, Inc., and the original Certificate of Incorporation of this Corporation was filed with
June 4, 2020	EX-10.1	Offer Letter, dated June 3, 2020, by and between iRhythm Technologies, Inc. and Douglas J. Devine. Exhibit 10.1 June 3, 2020 Douglas J. Devine, CPA Dear Doug: We are pleased to offer you the position of Chief Financial Officer with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefits from time to time as it deems neces
June 4, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizat
June 4, 2020	EX-99.1	iRhythm Technologies Announces CFO Transition Exhibit 99.1 iRhythm Technologies Announces CFO Transition SAN FRANCISCO, June 4, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that Douglas Devine has been appointed Chief Financial Officer (CFO), effective June 22, 2020. Mr. Devine will succeed Matthew Garrett, who has decided to step
June 2, 2020	SD	- SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT iRhythm Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 699 8th Street, Suite 600 San Francisco, California 94103 (Address of
May 14, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
May 8, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-37918 iRhythm Technologies, Inc. (Exact Name of R
May 7, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organizati
May 7, 2020	EX-99.1	iRhythm Technologies Announces First Quarter 2020 Financial Results Exhibit 99.1 iRhythm Technologies Announces First Quarter 2020 Financial Results SAN FRANCISCO, May 7, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2020. First Quarter 2020 Highlights •Revenue of $63.5 million for the three months en
April 29, 2020	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
April 24, 2020	EX-99.1	iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors Exhibit 99.1 iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors SAN FRANCISCO, April 23, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Clas
April 24, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 23, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiz
April 9, 2020	EX-99.1	iRhythm Technologies Announces Update on COVID-19 Impact and Response Announces Preliminary Revenue Results for First Quarter of 2020; Withdraws 2020 Financial Guidance Exhibit 99.1 iRhythm Technologies Announces Update on COVID-19 Impact and Response Announces Preliminary Revenue Results for First Quarter of 2020; Withdraws 2020 Financial Guidance SAN FRANCISCO, April 9, 2020 - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today provided an update on the impact the company i
April 9, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 9, 2020 iRhythm Technologies, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-37918 20-8149544 (State or other jurisdiction of incorporation or organiza
March 2, 2020	EX-4.3	Description of the Registrant's securities registered pursuant to section 12 of the securities exchange act of 1934. Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 iRhythm Technologies, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.0001 per share. As used in this summary, the terms “iRhythm,” “the Company,” “we,” “our” a
March 2, 2020	EX-4.4	First amendment to third amended and restated loan and security agreement FIRST AMENDMENT TO THIRD AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT This First Amendment to Third Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into this 26th day of February, 2020, by and between SILICON VALLEY BANK (“Bank”) and IRHYTHM TECHNOLOGIES, INC.
March 2, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-37918 iRhythm Technol
March 2, 2020	S-8	IRTC / iRhythm Technologies, Inc. S-8 - - S-8 S-8 As filed with the Securities and Exchange Commission on March 2, 2020 Registration No.

IT:1IRTC	156,00 €
GB:0A7L
DE:I25	152,00 €

IRTC / iRhythm Technologies, Inc. - Depositi SEC, Relazione annuale, dichiarazione di delega

Statistiche di base

SEC Filings

SEC Filings (Chronological Order)

Other Listings